What Doctors Don't Tell YouThe Pan European Trial in Adjuvant Colon Cancer-1 (PETACC-1) trial has been halted after preliminary results showed a high death rate from AstraZeneca's new drug, raltitrexed. ...
Methylphenidate (MPH) treatment 'may be associated with unacceptable side effects and risks' (J Clin Psychiatry, 1998; 59 [Suppl 7]: 42-9).
THALIDOMIDE: The Alien of the drug world
YOUR FRIENDLY DRUG DEALER: Yes, it’s the family GP
New research reveals that doctors need to think twice before prescribing antidepressants, and patients should think three times before taking them.
Another anti-inflammatory bites the dust. Another COX-2 inhibitor has been shot down by the FDA. Having spent the last two months reviewing the safety of the COX-2-selective non-steroidal anti-inflammatory drugs (NSAIDs), the US regulatory agency...
A drug for irritable bowel syndrome (IBS) which was linked to the deaths of at least five patients, within nine months of being licensed, may soon be back on the market.
Conventional treatment of high blood pressure is failing to prevent men from dying from heart disease in fact, it may even be increasing the risk of heart problems. ...
’Tis the season that brings to mind auld acquaintances, and Roaccutane (isotretinoin), the acne drug, is fully deserving of the biggest Drug of the Month welcome.
Mefloquine, the latest and greatest malaria drug, also comes with the worse side effects. The greatest of these is severe psychological disturbances, such as panic attacks and hallucinations, vom ...
